Top Selling Drugs of 2018? 5 of 10 predicted be Oncology Products
EvaluatePharma projects the best sellers of 2018. #2018 #drugs #pharmaceuticals #oncology
What will 2018 bring? PwC's outlines top health industry issues for new year.
PwC outlines what to look for in 2018. Click here for full PWC article. #PwC #2018 #healthcare
Measuring the return from pharmaceutical innovation 2017: Deloitte Report shows declining ROI
The eighth annual pharmaceutical innovation study by the Deloitte Centre for Health Solutions looks at the state of R&D in the biopharma...
Oncology Practice Trends and Pressures: Drug Pricing and Administrative Work
Recent article from Oncology Practice Management highlights the challenges oncologist face each day as they try to prioritize patient...
MSKCC Study uncovers Genetic Reasons Why Some People Respond to Immunotherapy Better than Others
"A new analysis finds that certain genes people are born with may play a critical role in whether or not checkpoint inhibitors will work....
Keytruda Ad makes top 10 TV ad spend in 2017
Merck will spend an estimated $12.5 million on TV ad spend on the 'It's TRU: Donna's Story - Living Longer Is Possible' ad. This brings...
PARP Inhibitor competition heating up and it won't be dominated by one player for ovarian or br
"The PARP inhibitor market is going to be split. The question is to what extent, and whether insurers, pharmacy benefit managers and...
CRI's Comprehensive Analysis of clinical immune-oncology
Cancer Research Institute publishes analysis in Annals of Oncology 2017 "Advances in immuno-oncology (IO) are revolutionizing the...
Oncology New Drug Approvals in 2017
Oncology Drugs Approved in 2017 thru Dec 8th Aliqopa (copanlisib); Bayer; For the treatment of follicular lymphoma , Approved September...
Rethinking the role of the Pharma Rep
In 1988, when I first managed a sales territory, the role of the representative was highly valued. A career as a pharmaceutical...